The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Clinical trial NCT05661643 · RECRUITING

Trial details

NCT number: NCT05661643
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2023-06-28
Primary completion: 2026-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.